Información de la revista
Lo más leído
909
Optic neuritis associated with COVID-19-related vaccinesMasoud Keikha, Mehdi Zandhaghighi, Shahram Shahraki Zahedani
Vacunas. 2023;24:158-9
909
776
Autoimmune diseases related to post-SARS-CoV-2 vaccination: A rheumatology perspectiveFarhad Dadgar, Jorge Casseb, Masoud Keikha
Vacunas. 2023;24:400-1
776
771
Efficacy of drug regimen with and without oseltamivir in hospitalized patients with COVID-19: A retrospective studyFazlollah Shokri, Saeed Rezapoor, Masoud Najafi, Mohsen Asadi, Mohammad Karimi alavije, Moussa Abolhassani, Mohammad Hossein Moieneddin, Amir Muhammad Ashrafi, ... Mostafa Rostamnezhad
Vacunas. 2023;24:141-9
771
708
Impact of vaccination on the entire population and dose-response relation of COVID-19Abdul Malek, Ashabul Hoque
Vacunas. 2023;24:278-90
708
606
Vacunación frente al SARS-CoV-2 en otoño de 2023: ¿a quién y cómo hay que vacunar?Fernando Moraga-Llop, Magda Campins-Martí
Vacunas. 2023;24:261-5
606
587
The polymorphisms of TNF-α related-gene and antibody production following third dose of COVID-19 vaccination: A pilot studyPhey Liana, Zen Hafy, Soilia Fertilita, Ella Amalia, Veny Larasati, Tungki Pratama Umar
Vacunas. 2023;24:273-7
587
583
Adverse events following COVID-19 vaccination among pregnant women attending primary health centers: An active-surveillance studyNarayana Goruntla, Basappa Karisetty, Nandini Nandini, Bharadwaj Bhupasamudram, Himaja Reddy Gangireddy, Kasturi Vishwanathasetty Veerabhadrappa, Joseph Obiezu Chukwujekwu Ezeonwumelu, Vishnuvandana Bandaru
Vacunas. 2023;24:291-7
583
583
Impacto de la vacunación contra SARS-CoV-2 en la incidencia de infección en ámbito escolarMaría Teresa Herrero-Diez, María Inés Salado-Valdivieso, Sara Carbajal-Domínguez, Marta Allué-Tango, Juan Carlos Villa-Caballero, Clara Berbel-Hernández
Vacunas. 2023;24:203-9
583
568
Incidence of sudden sensorineural hearing loss associated with BNT162b2 COVID-19 vaccine: Pooled results from register-based nationwide studiesPaulo Ricardo Martins-Filho
Vacunas. 2023;24:258-9
568
548
Factores asociados a la intención de vacunación contra el COVID-19 en Popayán, Cauca, ColombiaOmar Andrés Ramos Valencia, Yuliana Buitrón Gonzalez, Jorge Sotelo Sotelo Daza, Andrés Felipe Villaquiran
Vacunas. 2023;24:174-81
548
543
The status of COVID-19 vaccines in India: A reviewDeepak Kumar Jha, Kumar Pranay, Samiksha, Amit Kumar, Niti Yashvardhini
Vacunas. 2023;24:218-47
543
542
Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from GreecePetros Galanis, Aglaia Katsiroumpa, Irene Vraka, Vanessa Chrysagi, Olga Siskou, Olympia Konstantakopoulou, Theodoros Katsoulas, Parisis Gallos, Daphne Kaitelidou
Vacunas. 2023;24:210-7
542
540
COVID-19 immune response in adults post Measles-Rubella vaccinationSuwoyo Suwoyo, Erna Rahma Yani, Koekoeh Hardjito
Vacunas. 2023;24:341-7
540
527
Epidemiological study of vaccination against SARS-CoV-2 and its impact on COVID-19 progression in a cohort of patients in gran CanariaAlejandro de Arriba Fernández, José Luis Alonso Bilbao, Alberto Espiñeira Francés, Antonio Cabeza Mora, Ángela Gutiérrez Pérez, Miguel Ángel Díaz Barreiros
Vacunas. 2023;24:308-16
527
526
Situación actual y perspectivas de futuro de las vacunas frente al virus respiratorio sincitialJordi Reina, Elisa Gónzalez de Herrero
Vacunas. 2023;24:150-7
526
513
El fin de la emergencia internacional de salud pública por COVID-19: ¿y ahora qué?Núria Torner
Vacunas. 2023;24:164-5
513
506
Demographic and clinical characteristics and outcomes of COVID-19 patients admitted to a university hospital in the west of Iran: a retrospective study in the third waveYounes Jesmani, Arezoo Bozorgomid, Fatemeh Khosravi Shadmani, Ali Dehbani, Babak Sayad
Vacunas. 2023;24:182-9
506
495
An immunoinformatics approach to study the epitopes of SARS-CoV-2 helicase, Nsp13Sushant Kumar, Khushboo Kumari, Gajendra Kumar Azad
Vacunas. 2023;24:190-202
495
483
Knowledge and attitudes toward the COVID-19 vaccine among India's general rural populationRajesh Venkataraman, Umesh Yadav, Yogendra Shrestha, Sindhushree Narayanaswamy, Shree Harsha Pura Basavaraju
Vacunas. 2023;24:128-34
483
469
Quince años de vacunación frente al virus del papiloma humano en España. ActualizaciónF. Moraga-Llop
Vacunas. 2023;24:394-9
469